No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
ZOM Zomedica
- 0.1253
- +0.0053+4.42%
Close Dec 20 16:00 ET
- 0.1224
- -0.0029-2.31%
Post 19:58 ET
122.79MMarket Cap-1.93P/E (TTM)
0.1253High0.1196Low6.69MVolume0.1197Open0.1200Pre Close808.08KTurnover0.70%Turnover RatioLossP/E (Static)979.95MShares0.228552wk High0.61P/B120.50MFloat Cap0.117052wk Low--Dividend TTM961.66MShs Float2.9800Historical High--Div YieldTTM4.75%Amplitude0.0628Historical Low0.1200Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Zomedica Appoints New CFO to Drive Growth
Express News | Zomedica Corp - Jordan Succeeds Peter Donato
Express News | Zomedica Appoints Scott a. Jordan Executive Vice President, Finance & Chief Financial Officer
Zomedica Has Launched Its Third Equine-focused Assay-insulin For Equine Plasma-For Truforma In-Clinic Biosensor Testing Platform
Noble Financial Initiates Zomedica(ZOM.US) With Buy Rating, Announces Target Price $0.25
Zomedica Positioned for Growth With Strategic Acquisitions and Strong Financial Performance: Buy Recommendation
Heat List
US
Overall
Symbol
Price
% Chg
No Data